Back to Search Start Over

Advances in Neuropathic Pain

Authors :
Kenneth E. Schmader
M. Catherine Bushnell
Robert H. Dworkin
Linda R. Watkins
Charles R. Argoff
John D. Loeser
Mario Saltarelli
Michael C. Rowbotham
Robert R. Allen
Miroslav Backonja
Jennifer A. Haythornthwaite
David J. Hewitt
Sharon M. Weinstein
Christoph Stein
David R. Thompson
Mitchell B. Max
Bradley S. Galer
Mark S. Wallace
Dennis C. Turk
Gary J. Bennett
John T. Farrar
Source :
Archives of Neurology. 60:1524
Publication Year :
2003
Publisher :
American Medical Association (AMA), 2003.

Abstract

Chronic neuropathic pain, caused by lesions in the peripheral or central nervous system, comes in many forms. We describe current approaches to the diagnosis and assessment of neuropathic pain and discuss the results of recent research on its pathophysiologic mechanisms. Randomized controlled clinical trials of gabapentin, the 5% lidocaine patch, opioid analgesics, tramadol hydrochloride, and tricyclic antidepressants provide an evidence-based approach to the treatment of neuropathic pain, and specific recommendations are presented for use of these medications. Continued progress in basic and clinical research on the pathophysiologic mechanisms of neuropathic pain may make it possible to predict effective treatments for individual patients by application of a pain mechanism-based approach.

Details

ISSN :
00039942
Volume :
60
Database :
OpenAIRE
Journal :
Archives of Neurology
Accession number :
edsair.doi.dedup.....f49a4cd811a80bd2a38b46a58a9843c8
Full Text :
https://doi.org/10.1001/archneur.60.11.1524